|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print January 11, 2002
J Appl Physiol, 10.1152/jap.00927.2001
Submitted on September 6, 2001
Accepted on January 9, 2002
* To whom correspondence should be addressed. E-mail: sfreedma{at}caregroup.harvard.edu.
The mechanism by which Pseudomonas causes excessive inflammation in the cystic fibrosis lung is unclear. We've reported that arachidonic acid is increased and docosahexaenoic acid (DHA) decreased in lung, pancreas, and ileum from cftr-/- mice. Oral DHA corrected this defect and reversed the pathology. To determine which mediators regulate inflammation in lungs from cftr-/- mice and whether inhibition occurs with DHA, cftr-/- and wild-type (WT) mice were exposed to aerosolized Pseudomonas LPS. After 2 days of LPS, TNF-
, MIP-2 and KC levels in bronchoalveolar lavage (BAL) fluid were increased in cftr-/- compared to WT mice and not suppressed by pretreatment with oral DHA. Neutrophil levels were not different between cftr-/- and WT mice. After 3 days of aerosolized LPS, neutrophil concentration, TNF-
, the eicosanoids 6-keto PGF1
PGF2
PGE2 and thromboxane B2 were all increaed in BAL fluid from cftr-/- mice compared to WT controls. Oral DHA has no significant effect on TNF-
levels in cftr-/- mice. In contrast, neutrophils and eicosanoids were decreased in cftr-/- but not in WT mice treated with DHA indicating that the effects of DHA on these inflammatory parameters may be related to correction of the membrane lipid defect.
This article has been cited by other articles:
![]() |
C. Andersson, M. R. Al-Turkmani, J. E. Savaille, R. Alturkmani, W. Katrangi, J. E. Cluette-Brown, M. M. Zaman, M. Laposata, and S. D. Freedman Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism J. Lipid Res., August 1, 2008; 49(8): 1692 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez, A. M. van Heeckeren, D. Nichols, S. Gupta, J. F. Eastman, and P. B. Davis Peroxisome proliferator-activated receptor-{gamma} in cystic fibrosis lung epithelium Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L303 - L313. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saadane, S. Masters, J. DiDonato, J. Li, and M. Berger Parthenolide Inhibits I{kappa}B Kinase, NF-{kappa}B Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 728 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. White, D. Jiang, J. D. Burgess, I. R. Bederman, S. F. Previs, and T. J. Kelley Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L476 - L486. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guilbault, Z. Saeed, G. P. Downey, and D. Radzioch Cystic Fibrosis Mouse Models Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tabary, H. Corvol, E. Boncoeur, K. Chadelat, C. Fitting, J. M. Cavaillon, A. Clement, and J. Jacquot Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactions Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L588 - L596. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Blanco, M. M. Zaman, O. Junaidi, S. Sheth, R. K. Yantiss, I. A. Nasser, and S. D. Freedman Induction of colitis in cftr-/- mice results in bile duct injury Am J Physiol Gastrointest Liver Physiol, August 1, 2004; 287(2): G491 - G496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Freedman, P. G. Blanco, M. M. Zaman, J. C. Shea, M. Ollero, I. K. Hopper, D. A. Weed, A. Gelrud, M. M. Regan, M. Laposata, et al. Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism N. Engl. J. Med., February 5, 2004; 350(6): 560 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Serhan, S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R.-L. Moussignac Resolvins: A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals J. Exp. Med., October 21, 2002; 196(8): 1025 - 1037. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |